Biogenix Duo (NS1 Ag +IgG/IgM Ab) Dengue Rapid Card - 25 Test (BIR-005)

Description: The Biogenix Duo Dengue Rapid Card is an advanced diagnostic tool designed for the simultaneous qualitative detection of Dengue Virus NS1 antigen and Dengue virus-specific IgG/IgM antibodies in human serum, plasma, or whole blood. Configured for 25 tests, this comprehensive kit provides a dual approach to Dengue virus diagnosis, allowing healthcare professionals to assess both the early and convalescent phases of the infection.

Key Features:

1. Dual Detection Capability: The Duo Dengue Rapid Card is capable of detecting Dengue Virus NS1 antigen for early infection identification and Dengue virus-specific IgG/IgM antibodies for immune response assessment, offering a comprehensive diagnostic solution.

2. Rapid On-Site Results: With a rapid testing procedure, the kit provides on-the-spot results within a short timeframe. This feature is crucial for quick clinical decision-making, allowing healthcare professionals to promptly assess patient status.

3. Triple Specimen Compatibility: The test is compatible with human serum, plasma, and whole blood specimens, providing flexibility in sample collection and making it suitable for various healthcare settings.

4. 25-Test Configuration: The kit includes 25 tests, offering an efficient solution for healthcare facilities with moderate testing volumes. This configuration supports multiple screening sessions and facilitates comprehensive Dengue virus diagnosis.

Benefits:

1. Comprehensive Dengue Diagnosis: The dual detection capability allows for the comprehensive diagnosis of Dengue virus infection, covering both the early and convalescent phases. This aids in timely patient management and immune response assessment.

2. Rapid On-Site Results: The rapid card design enables quick and on-the-spot testing, providing timely results for immediate clinical decision-making and patient management.

3. Versatile Specimen Compatibility: Compatibility with human serum, plasma, and whole blood specimens enhances flexibility in sample collection, making the test adaptable to diverse healthcare settings and conditions.